|
US5811310A
(en)
|
1986-09-30 |
1998-09-22 |
Albert Einstein College Of Medicine Of Yeshiva Univ. |
The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
|
|
CA2017507C
(en)
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
US7408027B1
(en)
|
1991-12-06 |
2008-08-05 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften |
Tools for the diagnosis and treatment of Alzheimer's disease
|
|
WO1994013795A1
(en)
|
1992-12-14 |
1994-06-23 |
N.V. Innogenetics S.A. |
Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
|
|
US7427392B1
(en)
|
1994-11-14 |
2008-09-23 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
|
|
US20020086009A1
(en)
|
1996-03-13 |
2002-07-04 |
Koichi Ishiguro |
Anti-phosphorylated tau protein antibodies and methods for detecting alzheimer`s disease with the use of the same
|
|
AU5508798A
(en)
|
1996-11-19 |
1998-06-10 |
Trustees Of The University Of Pennsylvania, The |
Diagnostic and therapeutic reagents for alzheimer's disease
|
|
PT1036092E
(pt)
|
1997-12-03 |
2005-09-30 |
Biogen Inc |
Compos~icoes e metodos de proteinas hidrofobicamente modificadas
|
|
US6314469B1
(en)
|
1999-02-26 |
2001-11-06 |
I-Dns.Net International Pte Ltd |
Multi-language domain name service
|
|
JP2004503747A
(ja)
|
2000-07-11 |
2004-02-05 |
モレキュラー ジェリアトリクス コーポレイション |
結合物質の同定するための試薬と方法
|
|
GB0114719D0
(en)
*
|
2001-06-15 |
2001-08-08 |
Glaxo Group Ltd |
Compound
|
|
WO2003066649A1
(en)
|
2002-02-04 |
2003-08-14 |
Biomira Inc. |
Immunostimulatory, covalently lipidated oligonucleotides
|
|
ATE514707T1
(de)
*
|
2002-04-19 |
2011-07-15 |
Univ Toronto |
Immunologisches verfahren und zusammensetzungen für die behandlung der krankheit von alzheimer
|
|
AU2003292936A1
(en)
|
2002-12-24 |
2004-07-22 |
Neurochem (International) Limited |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
US8663650B2
(en)
|
2003-02-21 |
2014-03-04 |
Ac Immune Sa |
Methods and compositions comprising supramolecular constructs
|
|
EP1691666B1
(en)
|
2003-12-12 |
2012-05-30 |
University of Washington |
Catheterscope 3d guidance and interface system
|
|
US20050261475A1
(en)
|
2004-02-13 |
2005-11-24 |
Harvard Medical School |
Solid-phase capture-release-tag methods for phosphoproteomic analyses
|
|
US7238788B2
(en)
|
2004-02-18 |
2007-07-03 |
University Of Iowa Foundation |
Antibodies to phosphorylated tau, methods of making and methods of use
|
|
EP1879613B1
(en)
|
2005-05-05 |
2011-11-30 |
Merck Sharp & Dohme Corp. |
Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease
|
|
US7977314B2
(en)
|
2005-12-02 |
2011-07-12 |
Amorfix Life Sciences Limited |
Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
|
|
KR101152557B1
(ko)
|
2005-12-12 |
2012-09-07 |
에이씨 이뮨 에스.에이. |
치료 백신
|
|
WO2007068105A1
(en)
|
2005-12-12 |
2007-06-21 |
Robarts Research Institute |
Method of diagnosing amyotrophic lateral sclerosis
|
|
US8012936B2
(en)
|
2006-03-29 |
2011-09-06 |
New York University |
Tau fragments for immunotherapy
|
|
WO2008140639A2
(en)
|
2007-02-08 |
2008-11-20 |
Oligomerix, Inc. |
Biomarkers and assays for alzheimer's disease
|
|
CN101965365A
(zh)
|
2007-10-19 |
2011-02-02 |
伊缪纳斯制药株式会社 |
能够特异性结合Aβ寡聚体的抗体及其应用
|
|
CA2739318A1
(en)
|
2008-08-07 |
2010-02-11 |
Mercia Pharma, Llc |
Immunotherapeutic compositions for the treatment of alzheimer's disease
|
|
CN102365295A
(zh)
|
2009-01-30 |
2012-02-29 |
阿德利夫股份有限公司 |
构象动力肽
|
|
US9605054B2
(en)
|
2009-02-23 |
2017-03-28 |
The Board Of Trustees Of The University Of Illinois |
Composition and method for treating a tauopathy
|
|
HUE055739T2
(hu)
|
2009-03-18 |
2021-12-28 |
Ac Immune Sa |
Eljárás terápiás alkalmazásra
|
|
UA107571C2
(xx)
|
2009-04-03 |
2015-01-26 |
|
Фармацевтична композиція
|
|
CN106390107B
(zh)
|
2009-06-10 |
2019-12-31 |
纽约大学 |
病理tau蛋白的免疫靶向
|
|
JP2013500326A
(ja)
|
2009-07-30 |
2013-01-07 |
ファイザー バクシーンズ エルエルシー |
抗原性タウペプチドおよびその使用
|
|
AU2010291933B2
(en)
|
2009-09-14 |
2016-09-08 |
Banyan Biomarkers, Inc. |
Micro-RNA, autoantibody and protein markers for diagnosis of neuronal injury
|
|
CA2796722C
(en)
|
2010-04-19 |
2021-06-01 |
Nlife Therapeutics, S.L. |
Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
|
|
WO2012020124A1
(en)
|
2010-08-12 |
2012-02-16 |
Ac Immune S.A. |
Vaccine engineering
|
|
JP6027011B2
(ja)
|
2010-10-26 |
2016-11-16 |
エーシー イミューン ソシエテ アノニム |
疎水性部分によって修飾されたペプチドを含むリポソームベースの構築物
|
|
JP5826863B2
(ja)
|
2011-02-15 |
2015-12-02 |
イミュノジェン・インコーポレーテッド |
細胞傷害性ベンゾジアゼピン誘導体
|
|
ME03008B
(me)
|
2011-09-19 |
2018-10-20 |
Axon Neuroscience Se |
Terapija na osnovu proteina i dijagnoza patologije u којој posreduje tau u alcнajмerovoj bolesti
|
|
US20140314837A1
(en)
|
2011-09-23 |
2014-10-23 |
Ac Immune S. A. |
Vaccine Therapy
|
|
EP2770089B1
(en)
|
2011-10-21 |
2025-03-05 |
Mitsubishi Chemical Corporation |
Gallium NITRIDE SEMICONDUCTOR CRYSTAL
|
|
EP2659906A1
(en)
|
2012-05-01 |
2013-11-06 |
Affiris AG |
Compositions
|
|
US20140056901A1
(en)
|
2012-08-21 |
2014-02-27 |
The Institute For Molecular Medicine |
Anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies
|
|
US10501531B2
(en)
|
2013-03-13 |
2019-12-10 |
Prothena Biosciences Limited |
Tau immunotherapy
|
|
JP2017512751A
(ja)
|
2014-02-14 |
2017-05-25 |
アイピエリアン，インコーポレイティド |
タウペプチド、抗タウ抗体、およびそれらの使用方法
|
|
BR112016029579A2
(pt)
|
2014-06-26 |
2017-08-22 |
Janssen Vaccines & Prevention Bv |
anticorpos e fragmentos de ligação ao antígeno que se ligam especificamente à proteína tau associada a microtúbulos
|
|
NZ775762A
(en)
|
2015-06-05 |
2025-02-28 |
Genentech Inc |
Anti-tau antibodies and methods of use
|
|
BR112017028269A2
(pt)
|
2015-07-13 |
2018-09-04 |
Arvinas Inc |
composto, composição farmacêutica, uso de uma quantidade efetiva de um composto, estado ou condição de doença, e, método para identificar um composto.
|
|
EP3795061B1
(en)
|
2015-08-14 |
2025-12-03 |
Intuitive Surgical Operations, Inc. |
Systems and methods of registration for image-guided surgery
|
|
MY198194A
(en)
|
2016-05-02 |
2023-08-09 |
Prothena Biosciences Ltd |
Antibodies Recognizing Tau
|
|
UA128383C2
(uk)
|
2016-12-07 |
2024-07-03 |
Дженентек, Інк. |
Антитіло до тау-білка та спосіб його застосування
|
|
CN111787942B
(zh)
*
|
2017-10-25 |
2024-03-29 |
杨森制药公司 |
磷酸化Tau肽的组合物及其用途
|
|
EP3706795A4
(en)
|
2017-11-09 |
2021-10-13 |
Pinteon Therapeutics Inc. |
METHODS AND COMPOSITIONS FOR GENERATING AND USING HUMANIZED CONFORMATION SPECIFIC PHOSPHORYLATED TAU ANTIBODIES
|
|
MY206596A
(en)
|
2019-02-08 |
2024-12-25 |
Janssen Pharmaceuticals Inc |
Method of safe administration of phosphorylated tau peptide vaccine
|
|
JOP20210284A1
(ar)
|
2019-04-24 |
2023-01-30 |
Janssen Pharmaceuticals Inc |
الإعطاء غير المتجانس للقاحات تاو
|